We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IQVIA Earnings & Revenues Beat Estimates in Q3, Increase Y/Y
Read MoreHide Full Article
Key Takeaways
IQVIA's Q3 adjusted EPS rose 5.6% y/y to $3, topping estimates on 5.2% revenue growth.
Research and Development sales climbed 4.5%, while Contract Sales jumped 16.1% in the quarter.
IQVIA raised the 2025 revenue and EPS outlooks, with the mid-points above the Zacks Consensus Estimate.
IQVIA Holdings Analytics Inc. (IQV - Free Report) has reported impressive third-quarter 2025 results, wherein earnings and revenues beat the Zacks Consensus Estimate.
Adjusted earnings were $3 per share, outpacing the Zacks Consensus Estimate by 1.4% and rising 5.6% on a year-over-year basis. Total revenues of $4.1 billion surpassed the consensus estimate by a slight margin and grew 5.2% from the year-ago quarter.
The IQV stock has gained 44.9% over the past six months, outperforming the 13.2% growth of the industry it belongs to and the 26.6% rise of the Zacks S&P 500 Composite.
IQVIA Holdings Inc. Price, Consensus and EPS Surprise
The Research and Development segment’s revenues were $2.3 billion, increasing 4.5% from the year-ago quarter and 3.4% on a constant-currency basis. The metric surpassed our estimate of $2.2 billion.
Revenues from the Technology and Analytics segment were $1.6 billion, growing 5% from the year-ago quarter and 3.3% on a constant-currency basis. The metric missed our projection of $1.7 billion.
Contract Sales and Medical Solutions revenues increased 16.1% on a year-over-year basis to $209 million and increased 13.9% on a constant-currency basis. The metric beat our estimation of $181.7 million.
Adjusted EBITDA for the third quarter of 2025 was $949 million, a 1.1% rise from the year-ago quarter and outpaced our anticipation of $945.3 million.
The company exited the quarter with cash and cash equivalents of $1.8 billion compared with $2 billion in the preceding quarter. Long-term debt (less current portion) was $15 billion compared with $15.4 billion at the end of the second quarter of 2025.
Net cash generated from operating activities was $908 million and the capital expenditure for the quarter was $136 million. The company generated a free cash flow of $772 million in the quarter.
IQV’s 2025 Guidance
For 2025, IQVIA updated its revenue guidance to $16.15-$16.25 billion from the preceding quarter’s view of $16.10-$16.30 billion. The mid-point ($16.20 billion) of the guided range is higher than the Zacks Consensus Estimate of $16.16 billion.
IQV updated its earnings per share outlook to $11.85-$11.95 from the preceding quarter’s view of $11.75-$12.05. The mid-point ($11.90) of the guided range is higher than the consensus estimate of $11.86.
IQVIA’s adjusted EBITDA view was updated to $3.775-$3.800 billion from the preceding quarter’s view of $3.750-$3.825 billion.
Waste Connections’ adjusted earnings (excluding 33 cents from non-recurring items) of $1.44 per share surpassed the Zacks Consensus Estimate by 4.4% and increased 6.7% year over year. Revenues of $2.5 billion beat the consensus estimate marginally and grew 5.1% from the year-ago quarter.
EFX’s adjusted earnings were $2.04 per share, outpacing the Zacks Consensus Estimate by 5.7% and increasing 10.3% from the year-ago quarter. Total revenues of $1.5 billion surpassed the consensus estimate by 1.5% and grew 6.9% on a year-over-year basis.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
IQVIA Earnings & Revenues Beat Estimates in Q3, Increase Y/Y
Key Takeaways
IQVIA Holdings Analytics Inc. (IQV - Free Report) has reported impressive third-quarter 2025 results, wherein earnings and revenues beat the Zacks Consensus Estimate.
Adjusted earnings were $3 per share, outpacing the Zacks Consensus Estimate by 1.4% and rising 5.6% on a year-over-year basis. Total revenues of $4.1 billion surpassed the consensus estimate by a slight margin and grew 5.2% from the year-ago quarter.
The IQV stock has gained 44.9% over the past six months, outperforming the 13.2% growth of the industry it belongs to and the 26.6% rise of the Zacks S&P 500 Composite.
IQVIA Holdings Inc. Price, Consensus and EPS Surprise
IQVIA Holdings Inc. price-consensus-eps-surprise-chart | IQVIA Holdings Inc. Quote
IQVIA’s Quarterly Details
The Research and Development segment’s revenues were $2.3 billion, increasing 4.5% from the year-ago quarter and 3.4% on a constant-currency basis. The metric surpassed our estimate of $2.2 billion.
Revenues from the Technology and Analytics segment were $1.6 billion, growing 5% from the year-ago quarter and 3.3% on a constant-currency basis. The metric missed our projection of $1.7 billion.
Contract Sales and Medical Solutions revenues increased 16.1% on a year-over-year basis to $209 million and increased 13.9% on a constant-currency basis. The metric beat our estimation of $181.7 million.
Adjusted EBITDA for the third quarter of 2025 was $949 million, a 1.1% rise from the year-ago quarter and outpaced our anticipation of $945.3 million.
The company exited the quarter with cash and cash equivalents of $1.8 billion compared with $2 billion in the preceding quarter. Long-term debt (less current portion) was $15 billion compared with $15.4 billion at the end of the second quarter of 2025.
Net cash generated from operating activities was $908 million and the capital expenditure for the quarter was $136 million. The company generated a free cash flow of $772 million in the quarter.
IQV’s 2025 Guidance
For 2025, IQVIA updated its revenue guidance to $16.15-$16.25 billion from the preceding quarter’s view of $16.10-$16.30 billion. The mid-point ($16.20 billion) of the guided range is higher than the Zacks Consensus Estimate of $16.16 billion.
IQV updated its earnings per share outlook to $11.85-$11.95 from the preceding quarter’s view of $11.75-$12.05. The mid-point ($11.90) of the guided range is higher than the consensus estimate of $11.86.
IQVIA’s adjusted EBITDA view was updated to $3.775-$3.800 billion from the preceding quarter’s view of $3.750-$3.825 billion.
IQV carries a Zacks Rank #4 (Sell) at present.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Earnings Snapshot
Waste Connections (WCN - Free Report) reported impressive third-quarter 2025 results.
Waste Connections’ adjusted earnings (excluding 33 cents from non-recurring items) of $1.44 per share surpassed the Zacks Consensus Estimate by 4.4% and increased 6.7% year over year. Revenues of $2.5 billion beat the consensus estimate marginally and grew 5.1% from the year-ago quarter.
Equifax Inc. (EFX - Free Report) posted impressive third-quarter 2025 results.
EFX’s adjusted earnings were $2.04 per share, outpacing the Zacks Consensus Estimate by 5.7% and increasing 10.3% from the year-ago quarter. Total revenues of $1.5 billion surpassed the consensus estimate by 1.5% and grew 6.9% on a year-over-year basis.